Hospital Mãe de Deus

Porto Alegre, Rio Grande do Sul 90880-480

0 studies enrolling now · 7 studies all time

What they study most

Advanced Cancer, BRAF V600E-mutant Metastatic Colorectal Cancer, COVID-19, Cardiovascular Disease, Cervical Cancer, Coronary Revascularization, Myocardial Infarction, Neoplasms, Pancreatic Neoplasms, Refractory Generalized Myasthenia Gravis, Stroke

Studies at this site

• RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer — Stopped early
• EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction — Running, not enrolling
• A Study of AGEN2034 in Advanced Tumors and Cervical Cancer — Completed
• Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer — Completed
• Dapagliflozin in Respiratory Failure in Patients With COVID-19 — Completed
• Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study) — Completed
• Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer — Completed